Behandling af tumorinduceret hypercalcæmi Sikkerhedsprofilen for Bondronat stammer fra kontrollerede kliniske undersøgelser på den godkendte indikation og efter intravenøs indgift af Bondronat med de anbefalede doser.
Treatment of Tumour Induced Hypercalcaemia The safety profile for Bondronat in tumour-induced hypercalcaemia is derived from controlled clinical trials in this indication and after the intravenous administration of Bondronat at the recommended doses.